disclosure
play

Disclosure I have no relevant financial relationships with any - PDF document

Sep 04, 2023 •259 likes •491 views

10/9/2019 Point of Care Ultrasound UCSF Continuing Medical Education Cardiac Trevor Jensen, MD, MPH October 20-21, 2019 Disclosure I have no relevant financial relationships with any companies related to the content of this course. 1

  1. 10/9/2019 Point of Care Ultrasound UCSF Continuing Medical Education Cardiac Trevor Jensen, MD, MPH October 20-21, 2019 Disclosure I have no relevant financial relationships with any companies related to the content of this course. 1

  2. 10/9/2019 POCUS Cardiac and IVC Cardiac US • Keep it basic • Echocardiography is very complex • We will focus on the fundamentals that will help you care for your patients at the beside • These images will be used with the clinical history to make decisions on your patient 2

  3. 10/9/2019 Utility & Protocols • RUSH – Rapid Ultrasound in Shock – Patient is hypotensive or unresponsive • CLUE Protocol – Cardiopulmonary Limited Ultrasound Exam – Patient needs rapid assessment for heart failure • BLUE Protocol – Bedside Lung Ultrasound in Emergency – Patient is in respiratory failure Probe Selection Phased Array Low Frequency Small footprint to image between ribs 3

  4. 10/9/2019 How to Hold the Probe • Hold probe like a pencil • Brace hand on the patient • Larger motions that gradually become finer movements to improve image • Sufficient use of ultrasound gel Position of the Patient • Most likely will be supine in the ED/Hospital/ICU • Left Lateral Decubitus will usually result in improved images 4

  5. 10/9/2019 Sonographic Windows • 3 Windows • Parasternal • Apical • Subcostal Slide adapted with permission from Arun Nagdev Parasternal Short Parasternal Long Subcostal Apical 4-Chamber 5

  6. 10/9/2019 Parasternal Long: Probe + Position Parasternal Long Anatomy Images obtained from echocardiographer.org 6

  7. 10/9/2019 Parasternal Long Axis View RV RV LV LV RV RV LV LV Ao Mitral Valve Leaflets DTA Slide adapted with permission from Arun Nagdev Parasternal Long: Interpretation • Utility – Effusion – LV Function • Indices – Movement of mitral valve leaflet tips (EPSS) – Movement of lateral mitral valve annulus – LV Wall Thickening – Change in chamber size • Functional Categories (all views) – Hyperdynamic – Normal – Mildly decreased – Severely decreased 7

  8. 10/9/2019 Parasternal Long: Normal Parasternal Long: Abnormal 8

  9. 10/9/2019 Parasternal Long Tips • Stay close to sternum • Sonographic windows and axes vary • Difficult in COPD • Look for the Mitral Valve Parasternal Short: Position 9

  10. 10/9/2019 Parasternal Short: Orientation Parasternal Short: Orientation 10

  11. 10/9/2019 Parasternal Short: Interpretation • Utility – Gross LV systolic function – Assessed at level of papillary muscles – Regional wall motion abnormalities – RV size Parasternal Short: Normal 11

  12. 10/9/2019 Parasternal Short: Abnormal Parasternal Short Tips • Stay close to sternum • Sonographic windows and axes vary • Difficult in COPD • Look for the Mitral Valve 12

  13. 10/9/2019 Subcostal View: Position Subcostal View: Orientation 13

  14. 10/9/2019 Subcostal View: Interpretation • Utility – LV Systolic Function – Pericardial Effusion – Right atrium and ventricle size Subcostal View: Normal 14

  15. 10/9/2019 Subcostal View: Abnormal Subcostal 4 Chamber View • Tips: • Firm pressure • Inspiratory hold • Bend the knees • Bowel Gas? Try right of midline • Great for COPD patients 15

  16. 10/9/2019 Apical 4 Chamber • Utility – Systolic function – Chamber size – Valvular abnormalities – Doppler measurements • Challenges – most difficult view to obtain – prone to errors in interpretation Apical 4 Chamber: Orientation 16

  17. 10/9/2019 Apical 4 Chamber: Normal Apical 4 Chamber: Abnormal 17

  18. 10/9/2019 Apical 4 Chamber View • Tips : • Under the breast fold • Left lateral decubitus • End-expiratory hold • Aim sound waves toward right scapula Valvular disease 18

  19. 10/9/2019 Right Ventricle Evaluation IVC: Position 19

  20. 10/9/2019 IVC: Orientation IVC: Measurement 20

  21. 10/9/2019 IVC: Interpretation • Location: • 2‐3 cm caudal to RA or 0‐1 cm caudal to hepatic vein • Metrics • Max diameter: 2.1 cm • Collapsibility: 50% Don’t fall for Aorta! IVC Aorta 21

  22. 10/9/2019 Fan IVC/Aorta/IVC • IVC: Abnormal 22

  23. 10/9/2019 Summary • Focus on the basic exams + basic interpretations first – Most evidenced based for non‐cardiologists • Even basic exams have broad list of applications – Hypotension – Dyspnea – Volume overload – Unresponsiveness • Build towards more complex exams and protocols 23

Recommend

Will You Have to Will You Have to Rat Yourself Rat Yourself Out? Out? New Self-Disclosure

Will You Have to Will You Have to Rat Yourself Rat Yourself Out? Out? New Self-Disclosure

Will You Have to Will You Have to Rat Yourself Rat Yourself Out? Out? New Self-Disclosure 60-day overpayment refund Risks for the Unwary Stark Self-Disclosure Protocol Transparency reports Due diligence Dan Mulholland

54 views • 4 slides
Disclosure Mark Ashley DAC Beachcroft LLP Disclosure: Overview A vast topic! What is

Disclosure Mark Ashley DAC Beachcroft LLP Disclosure: Overview A vast topic! What is

Disclosure Mark Ashley DAC Beachcroft LLP Disclosure: Overview A vast topic! What is disclosure? Why documents are really important How it works in practice: The request for records Letter of Claim Litigation Other

778 views • 26 slides
Disclosure I currently have no relationships of any kind with any company whose products or

Disclosure I currently have no relationships of any kind with any company whose products or

Disclosure I currently have no relationships of any kind with any company whose products or services in any way relate to the practice of medicine, medical education or research. whose Disclosure In the interest of full disclosure, Dr. _____ (

226 views • 3 slides
4/14/2016 FINANCIAL DISCLOSURE FINANCIAL DISCLOSURE How Far Should We Go with the Endovascular

4/14/2016 FINANCIAL DISCLOSURE FINANCIAL DISCLOSURE How Far Should We Go with the Endovascular

4/14/2016 FINANCIAL DISCLOSURE FINANCIAL DISCLOSURE How Far Should We Go with the Endovascular Treatment of Advanced PAD in the Era of Health Care Reform? An Endocompetent Vascular Surgeons View I Have No Financial Relationships to

179 views • 14 slides
The disclosure debate: to tell or not to tell? Lucy Blake Lecture Outline Aim: context and

The disclosure debate: to tell or not to tell? Lucy Blake Lecture Outline Aim: context and

The disclosure debate: to tell or not to tell? Lucy Blake Lecture Outline Aim: context and complexity 1. Disclosure in context: who uses reproductive donation, why is non-disclosure an issue? 2. History/ culture of disclosure: Roots of

461 views • 19 slides
Hallux Rigidus: 1 st MTP Fusion Technique What is the best construct ? Disclosure Disclosure

Hallux Rigidus: 1 st MTP Fusion Technique What is the best construct ? Disclosure Disclosure

Hallux Rigidus: 1 st MTP Fusion Technique What is the best construct ? Disclosure Disclosure Consultant for: Extremity Medical Osteomed Crossroad Exactech BESPA Global Reviewer for : JBJS American JAAOS

606 views • 17 slides
DECLARATION OF CONFLICT OF INTEREST Disclosure: None Disclosure: None Independent study founded

DECLARATION OF CONFLICT OF INTEREST Disclosure: None Disclosure: None Independent study founded

DECLARATION OF CONFLICT OF INTEREST Disclosure: None Disclosure: None Independent study founded and performed within the Italian National Healthcare System. Approval by the relevant institutional ethical review boards, written informed

641 views • 21 slides
Forward-Looking Disclosure Forward-Looking Disclosure This information and other statements by

Forward-Looking Disclosure Forward-Looking Disclosure This information and other statements by

1 1 Forward-Looking Disclosure Forward-Looking Disclosure This information and other statements by the company may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to, among

401 views • 23 slides
Disclosure of tables Disclosure of statistical tables with primary and secondary suppressing of

Disclosure of tables Disclosure of statistical tables with primary and secondary suppressing of

Disclosure of tables Disclosure of statistical tables with primary and secondary suppressing of cell values within a SAS process chain Nordiskt SAS-mte, SSB, Oslo 2011 Anders Kraftling Methods Variety of methods to choose from in

668 views • 32 slides
SRI LANKA DEVELOPMENT UPDATE Public Disclosure Authorized MORE AND BETTER JOBS FOR AN UPPER

SRI LANKA DEVELOPMENT UPDATE Public Disclosure Authorized MORE AND BETTER JOBS FOR AN UPPER

Public Disclosure Authorized SRI LANKA DEVELOPMENT UPDATE Public Disclosure Authorized MORE AND BETTER JOBS FOR AN UPPER MIDDLE-INCOME COUNTRY Public Disclosure Authorized www.worldbank.org/sldu June 2018 #SLDU2018 Public Disclosure

640 views • 28 slides
Overview and research directions Public Disclosure Authorized Dhushyanth Raju Office of the

Overview and research directions Public Disclosure Authorized Dhushyanth Raju Office of the

Public Disclosure Authorized Public Disclosure Authorized Overview and research directions Public Disclosure Authorized Dhushyanth Raju Office of the Chief Economist, South Asia Region World Bank June 25, 2018 Public Disclosure Authorized

369 views • 22 slides
Disclosure

Disclosure

9th Annual UCSF Techniques in Complex Spine Surgery Course Disclosure

301 views • 17 slides
Relevant Financial Disclosure(s) <insert speaker name> Directions: 1) Insert your name

Relevant Financial Disclosure(s) <insert speaker name> Directions: 1) Insert your name

Relevant Financial Disclosure(s) <insert speaker name> Directions: 1) Insert your name above. 2) Choose the disclosure statement that reflects your disclosure status 3) Delete the other option and all RED text If NO relevant

205 views • 3 slides
I (and/or my coauthors) have something to disclose. Detailed disclosure information is

I (and/or my coauthors) have something to disclose. Detailed disclosure information is

3/9/2018 Hip Case Presentations Travis G. Maak, MD Department of Orthopaedics Hip & Knee Preservation Service Disclosure I (and/or my coauthors) have something to disclose. Detailed disclosure information is available via: The

315 views • 12 slides
Open Disclosure: Policy Revision 2019 HSE | Open Disclosure Background Patients who are harmed

Open Disclosure: Policy Revision 2019 HSE | Open Disclosure Background Patients who are harmed

Open Disclosure: Policy Revision 2019 HSE | Open Disclosure Background Patients who are harmed as a result of their health care must be dealt with in an open, honest, empathic and timely manner. They must also receive a sincere and meaningful

281 views • 7 slides
9/14/2019 DISCLOSURE Faculty: Erin Michos, MD Aspirin in Primary CVD Prevention: DISCLOSURE: I

9/14/2019 DISCLOSURE Faculty: Erin Michos, MD Aspirin in Primary CVD Prevention: DISCLOSURE: I

9/14/2019 DISCLOSURE Faculty: Erin Michos, MD Aspirin in Primary CVD Prevention: DISCLOSURE: I disclose that I have Is there any role in 2019? no relevant financial relationships with Erin D. Michos, MD, MHS, FACC, FAHA commercial interests

153 views • 14 slides
ERISA 401(k) Fee Litigation and New Fee Disclosure Regulations Strategies for Bringing and

ERISA 401(k) Fee Litigation and New Fee Disclosure Regulations Strategies for Bringing and

Presenting a live 90 minute webinar with interactive Q&A ERISA 401(k) Fee Litigation and New Fee Disclosure Regulations Strategies for Bringing and Defending Fee Claims and Complying with DOL's Disclosure Requirements THURS DAY, DECEMBER

346 views • 32 slides
AANP Region X Update 2018 Disclosure and Objectives Disclosure: No industry conflicts to report

AANP Region X Update 2018 Disclosure and Objectives Disclosure: No industry conflicts to report

AANP Region X Update 2018 Disclosure and Objectives Disclosure: No industry conflicts to report Objectives: Identify purpose and initiatives of AANP and national policy priorities and activities Discuss legislative trends for Region X

644 views • 33 slides
Long Run Sustainability PFRDA Second Pension Conclave Public Disclosure Authorized 4 February

Long Run Sustainability PFRDA Second Pension Conclave Public Disclosure Authorized 4 February

Public Disclosure Authorized Public Disclosure Authorized Expanding Coverage with Long Run Sustainability PFRDA Second Pension Conclave Public Disclosure Authorized 4 February 2016 William Price Senior Financial Sector Specialist World Bank

461 views • 20 slides
Texas Instruments & RFAB TI Information Selective Disclosure TI Information Selective

Texas Instruments & RFAB TI Information Selective Disclosure TI Information Selective

Texas Instruments & RFAB TI Information Selective Disclosure TI Information Selective Disclosure TI Information Selective Disclosure 2015 Corporate Citizenship Report Past 10 years Read more at TI.com/CCR TI Information

496 views • 13 slides
Venable SEC Update O C T O B E R 2 0 0 6 DEADLINES FOR COMPLIANCE WITH NEW DISCLOSURE RULES ON

Venable SEC Update O C T O B E R 2 0 0 6 DEADLINES FOR COMPLIANCE WITH NEW DISCLOSURE RULES ON

Venable SEC Update O C T O B E R 2 0 0 6 DEADLINES FOR COMPLIANCE WITH NEW DISCLOSURE RULES ON EXECUTIVE AND DIRECTOR COMPENSATION RAPIDLY APPROACHING Begin Preparing for 10-K and Proxy Statement Disclosure Now New Form 8-K Rules in Effect

386 views • 4 slides
Surveillance Why ? What ? When ? How ? Dr C Fryer FRCPC) 1 Disclosure;

Surveillance Why ? What ? When ? How ? Dr C Fryer FRCPC) 1 Disclosure;

Surveillance Why ? What ? When ? How ? Dr C Fryer FRCPC) 1 Disclosure; Disclosure; None. I have no conflicts. I have no industry financial relationships. Background: Background: Relapse is the

568 views • 9 slides
Beijing Mines and Money 2012 Investor Presentation Disclosure Statement Disclosure Statement

Beijing Mines and Money 2012 Investor Presentation Disclosure Statement Disclosure Statement

Beijing Mines and Money 2012 Investor Presentation Disclosure Statement Disclosure Statement Audalia Resources Limited (Audalia) has prepared this presentation based on information available to it. No representation or warranty

423 views • 29 slides
Company Presentation Jefferies Healthcare Conference, London November 2014 Important Disclosure

Company Presentation Jefferies Healthcare Conference, London November 2014 Important Disclosure

Company Presentation Jefferies Healthcare Conference, London November 2014 Important Disclosure Important Disclosure Important Disclosure Important Disclosure Materials and information provided during this presentation may contain

249 views • 24 slides

More recommend